Literature DB >> 17042504

N-terminal fragments of tau inhibit full-length tau polymerization in vitro.

Peleg M Horowitz1, Nichole LaPointe, Angela L Guillozet-Bongaarts, Robert W Berry, Lester I Binder.   

Abstract

The polymerization of the microtubule-associated protein, tau, into insoluble filaments is a common thread in Alzheimer's disease and in a variety of frontotemporal dementias. The conformational change required for tau to transition from an extended monomeric state to a filamentous state with a high beta-sheet content involves the extreme N-terminus coming into contact with distal portions of the molecule; however, these exact interactions are incompletely understood. Here we report that a construct representing amino acids 1-196 (Tau196), which itself does not polymerize, inhibits polymerization of full-length tau (hTau40) in vitro. In addition, we trace the inhibitory effect of Tau196 to amino acids 18-42 of the construct. We also provide evidence that the N-terminal tau fragments require a specific C-terminal region of tau (residues 392-421) to exert their inhibitory effect. The fragments are most effective at inhibiting polymerization when present during the initial 5 min; they remain in the soluble fraction of the polymerization reaction, and they increase the amount of soluble hTau40. The fragments also reduce the number and average length of filaments that are formed. Taken together, these results suggest that the N-terminal tau fragments inhibit hTau40 polymerization by interacting with a specific C-terminal sequence, thereby stabilizing a soluble conformation of tau.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17042504     DOI: 10.1021/bi061325g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  36 in total

1.  Protein τ-mediated effects on rat hippocampal choline transporters CHT1 and τ-amyloid β interactions.

Authors:  Zdena Kristofikova; Daniela Ripova; Katerina Hegnerová; Jana Sirova; Jiri Homola
Journal:  Neurochem Res       Date:  2013-07-04       Impact factor: 3.996

2.  The amino terminus of tau inhibits kinesin-dependent axonal transport: implications for filament toxicity.

Authors:  Nichole E LaPointe; Gerardo Morfini; Gustavo Pigino; Irina N Gaisina; Alan P Kozikowski; Lester I Binder; Scott T Brady
Journal:  J Neurosci Res       Date:  2009-02       Impact factor: 4.164

3.  Competing interactions stabilize pro- and anti-aggregant conformations of human Tau.

Authors:  Susanne Wegmann; Jonas Schöler; Christian A Bippes; Eckhard Mandelkow; Daniel J Muller
Journal:  J Biol Chem       Date:  2011-04-15       Impact factor: 5.157

4.  Azaphilones inhibit tau aggregation and dissolve tau aggregates in vitro.

Authors:  Smita R Paranjape; Andrew P Riley; Amber D Somoza; C Elizabeth Oakley; Clay C C Wang; Thomas E Prisinzano; Berl R Oakley; T Chris Gamblin
Journal:  ACS Chem Neurosci       Date:  2015-04-15       Impact factor: 4.418

5.  Inhibition of Tau aggregation by three Aspergillus nidulans secondary metabolites: 2,ω-dihydroxyemodin, asperthecin, and asperbenzaldehyde.

Authors:  Smita R Paranjape; Yi-Ming Chiang; James F Sanchez; Ruth Entwistle; Clay C C Wang; Berl R Oakley; T Chris Gamblin
Journal:  Planta Med       Date:  2014-01-10       Impact factor: 3.352

6.  Calpain-mediated tau cleavage: a mechanism leading to neurodegeneration shared by multiple tauopathies.

Authors:  Adriana Ferreira; Eileen H Bigio
Journal:  Mol Med       Date:  2011-03-21       Impact factor: 6.354

Review 7.  Amyloidogenesis of Tau protein.

Authors:  Bartosz Nizynski; Wojciech Dzwolak; Krzysztof Nieznanski
Journal:  Protein Sci       Date:  2017-09-13       Impact factor: 6.725

Review 8.  It's all about tau.

Authors:  Cheril Tapia-Rojas; Fabian Cabezas-Opazo; Carol A Deaton; Erick H Vergara; Gail V W Johnson; Rodrigo A Quintanilla
Journal:  Prog Neurobiol       Date:  2018-12-31       Impact factor: 11.685

9.  Analysis of isoform-specific tau aggregates suggests a common toxic mechanism involving similar pathological conformations and axonal transport inhibition.

Authors:  Kristine Cox; Benjamin Combs; Brenda Abdelmesih; Gerardo Morfini; Scott T Brady; Nicholas M Kanaan
Journal:  Neurobiol Aging       Date:  2016-07-29       Impact factor: 4.673

10.  Effect of Pin1 or microtubule binding on dephosphorylation of FTDP-17 mutant Tau.

Authors:  Kensuke Yotsumoto; Taro Saito; Akiko Asada; Takayuki Oikawa; Taeko Kimura; Chiyoko Uchida; Koichi Ishiguro; Takafumi Uchida; Masato Hasegawa; Shin-ichi Hisanaga
Journal:  J Biol Chem       Date:  2009-04-28       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.